Preimplantation Factor (PIF) Research

Exploring immune modulation from embryonic development for cancer, immunology, and regenerative medicine.

Harnessing Natural Immune Modulation

Preimplantation Factor (PIF) is a molecule discovered at the earliest stages of embryonic development that naturally modulates immune responses to allow pregnancy to proceed. NESA researchers, including Prof. Eytan Barnea (USA) who first detected the protein, have explored PIF’s potential applications beyond obstetrics—in immunology for regulating autoimmune conditions and inflammation, in cancer treatment for strengthening natural anti-cancer responses, in obstetrics for improving outcomes in recurrent pregnancy loss, and in regenerative medicine for supporting tissue healing and reducing harmful fibrosis after surgery. Current collaborations with European institutions on clinical applications demonstrate NESA’s approach of taking fundamental scientific discoveries and exploring practical applications to improve patient outcomes.